http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 20 Oct 2026 08:45:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html <div class="xn-content"> <p><i>New proprietary Thykamine^™ 0.1% formulation expands Devonian's clinical development program into supportive oncology, with a potential differentiated regulatory pathway.</i></p> <p><b>KEY HIGHLIGHTS</b></p> <ul type="disc"> <li>Significant clinical milestone: <span value="ACORN:1715008722" idsrc="xmltag.org" >Health Canada</span> authorizes a 150-patient, randomized, double-blind, http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Receives+Health+Canada+Authorization+to+Evaluate+Novel+Thykamine%E2%84%A2+Formulation+for+Prevention+of+Radiation-Induced+Skin+Injury+in+Breast+Cancer+Patients/27207367.html Tue, 20 Oct 2026 08:45:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>Oct. 16, 2026</chron></span> /PRNewswire/ --<b> <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) today provides an update on its proposed listing on the NYSE American in connection with its initial public offering in <location value="LC/us" idsrc="xmltag.org" >the United States</location> (the "Offering"), as initially announced on <chron>July 27, 2026</chron>, and subsequently updated in the Company's press releases dated <chron>August 18, 2026</chron>, and <chron>September 11, 2026</chron>.</p> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Provides+Update+on+its+Planned+NYSE+American+Listing/27196551.html Fri, 16 Oct 2026 10:01:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 11, 2026</chron></span> /PRNewswire/ -- <b><span value="AMEX:DHGR" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>September 16, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Inc.+Anticipates+to+Commence+Trading+on+the+NYSE+American/27052774.html Fri, 11 Sep 2026 16:00:00 -0400 DHGR DVHGF GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html <div class="xn-content"> <ul type="disc"><li>Validated HPLC-MS, NMR and a validated cell-based biological potency assay using the U937 human cell line, with MIP-1β as a biological marker of Thykamine™'s anti-inflammatory activity, provide complementary chemical and biological measures of Thykamine™ and demonstrate reliable batch-to-batch consistency.</li></ul><p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announced the successful independent validation and integration of key analytical and biological quality-control technologies into the extraction and manufacturing process for Thykamine™, http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html Tue, 01 Sep 2026 08:45:00 -0400 DHGR GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html <div class="xn-content"> <ul type="disc"><li>Validated HPLC-MS, NMR and a validated cell-based biological potency assay using the U937 human cell line, with MIP-1β as a biological marker of Thykamine™'s anti-inflammatory activity, provide complementary chemical and biological measures of Thykamine™ and demonstrate reliable batch-to-batch consistency.</li></ul><p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announced the successful independent validation and integration of key analytical and biological quality-control technologies into the extraction and manufacturing process for Thykamine™, http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html Tue, 01 Sep 2026 08:45:00 -0400 DHGR GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html <div class="xn-content"> <ul type="disc"><li>Validated HPLC-MS, NMR and a validated cell-based biological potency assay using the U937 human cell line, with MIP-1β as a biological marker of Thykamine™'s anti-inflammatory activity, provide complementary chemical and biological measures of Thykamine™ and demonstrate reliable batch-to-batch consistency.</li></ul><p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announced the successful independent validation and integration of key analytical and biological quality-control technologies into the extraction and manufacturing process for Thykamine™, http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html Tue, 01 Sep 2026 08:45:00 -0400 DHGR GSD http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html <div class="xn-content"> <ul type="disc"><li>Validated HPLC-MS, NMR and a validated cell-based biological potency assay using the U937 human cell line, with MIP-1β as a biological marker of Thykamine™'s anti-inflammatory activity, provide complementary chemical and biological measures of Thykamine™ and demonstrate reliable batch-to-batch consistency.</li></ul><p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Sept. 1, 2026</chron></span> /PRNewswire/ -- <span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announced the successful independent validation and integration of key analytical and biological quality-control technologies into the extraction and manufacturing process for Thykamine™, http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Strengthens+Thykamine%E2%84%A2+Manufacturing+Platform+with+Validated+Chemical-Composition+Fingerprinting+and+Biological+Potency+Assay/27009553.html Tue, 01 Sep 2026 08:45:00 -0400 DHGR GSD http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Aug. 18, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>August 21, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> of the Company's listing application and continued compliance with the exchange rules. The Company will remain http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html Tue, 18 Aug 2026 08:45:00 -0400 DVHGF GSD O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Aug. 18, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>August 21, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> of the Company's listing application and continued compliance with the exchange rules. The Company will remain http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html Tue, 18 Aug 2026 08:45:00 -0400 DVHGF GSD O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUEBEC</location></span>, <span class="legendSpanClass"><chron>Aug. 18, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span> ("Devonian" or the "Company") </b>(TSXV: GSD) (OTCQB: DVHGF) is pleased to announce that in connection with an underwritten public offering, it anticipates to list its common shares and warrants offered on the <span>NYSE American LLC</span> with trading expected to commence as early as <chron>August 21, 2026</chron> under the symbols "DHGR" and "DHGR WS", respectively, subject to market conditions and final authorization by the <span>NYSE American LLC</span> of the Company's listing application and continued compliance with the exchange rules. The Company will remain http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Anticipates+to+Commence+Trading+on+the+NYSE+American/26941268.html Tue, 18 Aug 2026 08:45:00 -0400 DVHGF GSD O.47005133